AR032284A1 - NUCLEAR TRANSFER WITH SELECTED DONOR CELLS - Google Patents

NUCLEAR TRANSFER WITH SELECTED DONOR CELLS

Info

Publication number
AR032284A1
AR032284A1 ARP000104816A ARP000104816A AR032284A1 AR 032284 A1 AR032284 A1 AR 032284A1 AR P000104816 A ARP000104816 A AR P000104816A AR P000104816 A ARP000104816 A AR P000104816A AR 032284 A1 AR032284 A1 AR 032284A1
Authority
AR
Argentina
Prior art keywords
cells
reconstituted
cell
nutraceutical
pharmaceutical
Prior art date
Application number
ARP000104816A
Other languages
Spanish (es)
Inventor
David Wells
Original Assignee
Agres Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agres Ltd filed Critical Agres Ltd
Publication of AR032284A1 publication Critical patent/AR032284A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/99—Coculture with; Conditioned medium produced by genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/10—Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Psychology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)

Abstract

Un método de transferencia nuclear, caracterizado porque comprende la seleccion y segregacion de células G1 de una poblacion proliferativa o no proliferativa de células donantes y la transferencia de un nucleo de dicha célula G1 segregada una célula receptora enucleada. Este método es ventajoso en comparacion con el arte previo debido a que provee certeza en cuanto a la etapa del ciclo celular en que se encuentran los nucleos donantes y permite la produccion de células embrionarias transgénicas o no transgénicas, embriones reconstituidos y animales completos para aplicaciones agrícolas, farmacéuticas, nutracéuticas y biomédicas. También se divulga un embrion animal reconstituido, un animal no humano clonado, progenie y descendientes de este ultimo, una línea celular embrionaria y uso de esta ultima, métodos para producir la misma y métodos de clonacion terapéutica para tratamiento de una enfermedad, para el descubrimiento de drogas, de xenotransplante y de terapia genética reconstituidos y animales completos para aplicaciones agrícolas, farmacéuticas, nutracéuticas y biomédicas.A method of nuclear transfer, characterized in that it comprises the selection and segregation of G1 cells from a proliferative or non-proliferative population of donor cells and the transfer of a nucleus from said segregated G1 cell to an enucleated receptor cell. This method is advantageous compared to the prior art because it provides certainty as to the stage of the cell cycle in which the donor nuclei are found and allows the production of transgenic or non-transgenic embryonic cells, reconstituted embryos and complete animals for agricultural applications. , pharmaceutical, nutraceutical and biomedical. A reconstituted animal embryo, a cloned non-human animal, progeny and descendants of the latter, an embryonic cell line and use of the latter, methods to produce the same and therapeutic cloning methods for treatment of a disease, for the discovery, are also disclosed. of reconstituted drugs, xenotransplantation and gene therapy and complete animals for agricultural, pharmaceutical, nutraceutical and biomedical applications.

ARP000104816A 1999-09-14 2000-09-14 NUCLEAR TRANSFER WITH SELECTED DONOR CELLS AR032284A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ337792A NZ337792A (en) 1999-09-14 1999-09-14 Nuclear transfer and use in cloning

Publications (1)

Publication Number Publication Date
AR032284A1 true AR032284A1 (en) 2003-11-05

Family

ID=19927507

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104816A AR032284A1 (en) 1999-09-14 2000-09-14 NUCLEAR TRANSFER WITH SELECTED DONOR CELLS

Country Status (8)

Country Link
JP (1) JP2004500038A (en)
CN (1) CN1424870A (en)
AR (1) AR032284A1 (en)
AU (1) AU784371B2 (en)
DE (1) DE10084987T1 (en)
GB (1) GB2369828B (en)
NZ (1) NZ337792A (en)
WO (1) WO2001019182A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122177B2 (en) 2000-01-20 2006-10-17 Diabcell Pty Ltd. Preparation and xenotransplantation of porcine islets
JP2006508676A (en) * 2002-12-10 2006-03-16 ジーティーシー バイオセラピューティックス インコーポレイテッド Methods and systems utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer
JP2006081542A (en) * 2004-08-18 2006-03-30 Institute Of Physical & Chemical Research Method for creating clone mammal
JP2010075099A (en) * 2008-09-26 2010-04-08 Japan Science & Technology Agency Method for screening mammal nuclear transplantation embryo, nonhuman mammal nuclear transplantation embryo, clone nonhuman mammal and screening kit
EP3188763B1 (en) * 2014-09-02 2020-05-13 The Regents of The University of California Methods and compositions for rna-directed target dna modification
CN105483216B (en) * 2015-11-30 2019-01-15 四川农业大学 A kind of method of rabbit CETP genetic test meat breeding
CN108624621B (en) * 2018-01-17 2019-04-12 中国科学院上海生命科学研究院 The preparation method of the somatic cell clone animal of non-human primates
JP2023516484A (en) 2020-03-11 2023-04-19 ビット バイオ リミテッド Hepatocyte production method
CN111793671A (en) * 2020-07-22 2020-10-20 中国农业大学 Optimized preparation method of chromosome suspension suitable for binary flow sorting of sheep chromosomes
CN112715479A (en) * 2021-01-06 2021-04-30 吉沙阿牛 Goat ecological cycle breeding method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1067834A4 (en) * 1998-03-16 2002-01-23 Garelag Pty Ltd Porcine nuclear transfer

Also Published As

Publication number Publication date
JP2004500038A (en) 2004-01-08
NZ337792A (en) 2002-03-28
WO2001019182A1 (en) 2001-03-22
GB2369828A (en) 2002-06-12
DE10084987T1 (en) 2003-04-17
CN1424870A (en) 2003-06-18
AU7462400A (en) 2001-04-17
AU784371B2 (en) 2006-03-23
GB0205915D0 (en) 2002-04-24
GB2369828B (en) 2004-12-01

Similar Documents

Publication Publication Date Title
Eggan et al. Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation
Wang et al. Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection
George et al. Familial dysautonomia model reveals Ikbkap deletion causes apoptosis of Pax3+ progenitors and peripheral neurons
Meredith et al. Overactive bladder and incontinence in the absence of the BK large conductance Ca2+-activated K+ channel
Alenina et al. Growth retardation and altered autonomic control in mice lacking brain serotonin
Shemer et al. Structure of the imprinted mouse Snrpn gene and establishment of its parental-specific methylation pattern
Sun et al. Specificity and efficiency of reporter expression in adult neural progenitors vary substantially among nestin‐CreERT2 lines
Liu et al. Generation of a monkey with MECP2 mutations by TALEN-based gene targeting
Tyynismaa et al. Mouse models of mitochondrial DNA defects and their relevance for human disease
Barber et al. Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion
Masubuchi et al. Protein phosphatase PHLPP1 controls the light-induced resetting of the circadian clock
Maurya et al. Positive and negative regulation of Gli activity by Kif7 in the zebrafish embryo
Ma et al. The effects of DNA double-strand breaks on mouse oocyte meiotic maturation
Zeng et al. EHMT2 and SETDB1 protect the maternal pronucleus from 5mC oxidation
AR032284A1 (en) NUCLEAR TRANSFER WITH SELECTED DONOR CELLS
Zhang et al. Expression patterns and potential biological roles of Dip2a
Hook et al. Functional identity of the gamma tropomyosin gene: Implications for embryonic development, reproduction and cell viability
Karadurmus et al. GPRIN3 controls neuronal excitability, morphology, and striatal-dependent behaviors in the indirect pathway of the striatum
Katoh et al. Fluorescent visualisation of the hypothalamic oxytocin neurones activated by cholecystokinin‐8 in rats expressing c‐fos‐enhanced green fluorescent protein and oxytocin‐monomeric red fluorescent protein 1 fusion transgenes
Choi et al. Simultaneous deletion of floxed genes mediated by CaMKIIα-Cre in the brain and in male germ cells: application to conditional and conventional disruption of Goα
Dann New technology for an old favorite: lentiviral transgenesis and RNAi in rats
Coppola et al. Epibranchial ganglia orchestrate the development of the cranial neurogenic crest
Andrae et al. Characterization of platelet-derived growth factor-A expression in mouse tissues using a lacZ knock-in approach
Kong et al. Generation of Elf5‐Cre knockin mouse strain for trophoblast‐specific gene manipulation
McGee et al. Golga5 is dispensable for mouse embryonic development and postnatal survival

Legal Events

Date Code Title Description
FB Suspension of granting procedure